On Going Projects


Epstein-Barr Virus (EBV) Antibody Response Patterns in Western and Asian EBV-associated Nasopharyngeal Carcinoma (NPC) 

Approved 08 Jul 2020

Epstein-Barr virus antibody pattern in head and neck cancer outside nasophayngeal carcinoma

Approved 05 Aug 2020

A descriptive analysis of upper gum tumours involving the antrum and paranasal sinus tomours from the Head and Neck 5000 study cohort

Approved 08 January 2020

Metabolizing enzymes and tobacco-related cancer risk: Replication of results

Approved 27 November 2019

Genome Wide Association Study of Radiotoxicity in Head and Neck Cancer

Approved 13 November 2019

The effect of statin drugs on the risk and progression of head and neck squamous cell carcinoma (HNSCC)

Approved 16 October 2019

Translational studies of HEAD and neck cancer in South America and Europe (HEADSpAcE)

Approved 04 July 2019

Validating the PredicTR-OPC treatment response classifier for oropharyngeal cancer (PredicTR 2)

Approved 13 May 2019

Gustatory Function Following Treatment for Head and Neck Cancer

Approved 17 April 2019

Cancer of Unknown Primary (TCGA Project)

Approved 17 April 2019

Defining the tumour microenvironment of salivary gland malignancies: do immune and neurogenic related biomarkers predict clinical outcome?

Approved 17 April 2019

Body mass index at diagnosis and prognostic significance on head and neck cancer survival

Approved 17 October 2018

Appearance-related distress amongst head and neck cancer patients during the first year post-diagnosis

Approved 22 August 2018

Using saliva to identify human papillomavirus driven oropharyngeal cancers

Approved 22 August 2018

Epstein-Barr virus specific antibody and RNA signatures in nasopharyngeal cancer

Approved 13 June 2018

Quality of Life following treatment for oropharyngeal carcinoma; a comparison of surgery versus non-surgical therapy

Approved 16 May 2018

Quality of Life following treatment for early glottic cancer; a comparison of surgery versus radiotherapy

Approved 16 May 2018

To clarify the role of human papillomavirus in head and neck cancer by identifying HPV driven cancers

Approved 11 April 2018

Testing a longitudinal predictor-process-outcome model of clinical and well-being outcomes for patients with head and neck cancer

Approved 11 January 2018

Genome Wide Association Study of Head and Neck Cancer progression

Approved 22 November 2017

Metabolic signatures of prognosis in Head and Neck 5000

Approved 18 August 2017

The role of germline and somatic DNA mutations in oral and oropharyngeal cancers (Voyager) 

Approved 21 July 2017

Primary malignant salivary gland tumours from Head and Neck 5000 - an observational study

Approved 21 July 2017

Experiencing a Diagnosis of Head & Neck Cancer

Approved 26 October 2016

Exploring mechanisms linking lifestyle and dietary factors to oral and oropharyngeal cancer progression

Approved 26 October 2016

Defining groups of patients using the EORTC C30. EORTC H&N35. EQ5D-5L and UW-QOL as part screening in clinical practice

Approved 17 June 2016

What will I be like one year after head and neck cancer treatment?

Approved 17 June 2016

Factors that determine health related quality of life one year following the diagnosis of head and neck cancer

Approved 17 June 2016

Trajectory, determinants and sequelae of speech, voice and swallowing in people with head and neck cancer

Approved 17 June 2016

The design and testing of path model to summarise the development of distress and fears of recurrence in patients with head & neck cancer one year following diagnosis

Approved 15 April 2016

Identifying epigenetic biomarkers in cancers of the head and neck

Approved 15 April 2016

The construction of a percentile calculator for identifying the rarity of fears of cancer (FCR) in head and neck cancer patients

Approved 15 April 2016

Human papilloma virus serology in participants in Head & Neck 5000

Approved 15 April 2016